When the Immune System Attacks Your Own Cells
The immune system is designed to fight off infections. To do this, it must be able to tell the difference between our own cells (and leave them alone) versus invading bacteria or viruses (and attack them). As we age, our cells are altered by “oxidative” damage and accumulation of debris, which can cause the immune system to attack our own cells. Oxidative damage occurs when our bodies produce very reactive molecules that can adversely interact with other molecules inside of our cells. The resulting “inflammation” can contribute to a number of age-related diseases, such as arthritis, heart disease, Alzheimer’s disease, and age-related macular degeneration (AMD).
There is strong evidence that inflammation plays a role in AMD. Genetic studies show that certain DNA sequence changes in “complement” genes (a part of the immune system) can significantly alter the risk of AMD. Further, complement proteins have been found in drusen, which are deposits that form under the retinas of patients with AMD. Blood samples from AMD patients have higher levels of complement proteins and other indicators of inflammation including C-reactive protein and interleukin 6. During post mortem examination, eyes that have been donated by persons with AMD show retinal invasion by immune cells (view a medical illustration of eye anatomy).
These findings suggest that diminishing inflammation and controlling the immune system within the retina could be helpful therapeutic approaches. The key will be to determine the most effective ways to diminish harmful inflammation without impairing the ability of the body or the eye to fight off infections, or causing other unwanted side effects.
Researchers have provided increased understanding of the mechanisms by which the immune system injures the retina, as well as model systems for testing potential drugs. Studies have been conducted using human genetics, retinal cells grown in plastic dishes, genetically modified mice, post mortem human retinas that have been donated to research, and human clinical trials.
While two phase III trials by Genentech targeting the complement protein called factor D in geographic atrophy patients were not successful, a phase III trial by Apellis targeting a different complement protein called C3 showed promising results.
Steps You Can Take Now
In the meantime, a number of epidemiological studies have shown that diet can influence the risk of AMD. Diet can affect inflammation throughout the body, and diets known to reduce systemic inflammation are associated with decreased AMD risk. These diets are generally Mediterranean-style, which are high in vegetables and fruits, with fish twice a week, and include a moderate amount of nuts, while keeping red meat and processed snack foods to a minimum.
Smoking, a strong risk factor for AMD, causes oxidative damage and inflammation. Smokers should try all possible approaches to quit. Read more about prevention of macular degeneration.
Research in coming years will undoubtedly reveal specific mechanisms of AMD-associated inflammation and provide new treatments to increase the chance that AMD patients will maintain good quality vision.
- Macular Degeneration Toolkit (Helpful Information to Understand and Manage Macular Degeneration)
- Expert Information on Macular Degeneration (Articles)
- BrightFocus Chats (Audio Presentations on Macular Degeneration)
- Inflammation in Early Macular Degeneration (Audio and Transcript)
BrightFocus Research Concerning the Immune System and Macular Degeneration
- Mouse Models For Studying Factors That Control Inflammation in AMD
- Modeling Immune Response and Oxygen Radical Injury due to Tobacco Smoke in Age-Related Macular Degeneration
- Can Proteins Block Inflammation in the Eye and Ameliorate AMD-Pathology?
- Inflammation as a Trigger of Age Related Macular Degeneration
- The Role of Lipofuscin Pigments and Chronic Inflammation as a Cause of Macular Degeneration
- Inflammation and AMD
- Control of Inflammatory Responses in the Retina
- Targeting Inflammation in Age-Related Macular Degeneration
- A New Target for the Treatment of Alzheimer's Disease
- Resistance to Oxidative Stress: A New Strategy for AMD
- Investigating if an Uncontrolled Immune Response to Your Own Damaged Cells Causes the Progression of AMD
- The Inflammatory Cells of the Choroid in Age-Related Macular Degeneration
- Novel Mechanism for Retinal Deposit Formation in Age-Related Macular Degeneration
This content was last updated on: December 3, 2019
The information provided here is a public service of the BrightFocus Foundation and should not in any way substitute for personalized advice of a qualified healthcare professional; it is not intended to constitute medical advice. Please consult your physician for personalized medical advice. BrightFocus Foundation does not endorse any medical product, therapy, or resources mentioned or listed in this article. All medications and supplements should only be taken under medical supervision. Also, although we make every effort to keep the medical information on our website updated, we cannot guarantee that the posted information reflects the most up-to-date research.
These articles do not imply an endorsement of BrightFocus by the author or their institution, nor do they imply an endorsement of the institution or author by BrightFocus.
Some of the content may be adapted from other sources, which will be clearly identified within the article.